Maxillary pain is the first indication of the presence of multiple myeloma: A case report

Zhao,Xiao   Jiao; Sun,Jian; Wang,Ying  Deng; Wang,Li

doi:10.3892/mco.2013.200

Maxillary pain is the first indication of the presence of multiple myeloma: A case report

Authors:
- Xiao Jiao Zhao
- Jian Sun
- Ying Deng Wang
- Li Wang
View Affiliations

Affiliations: Division of Nephrology, Shanghai Ninth Peoples' Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200011, P.R. China, Division of Oral and Maxillofacial Surgery, Shanghai Ninth Peoples' Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200011, P.R. China
Published online on: October 14, 2013 https://doi.org/10.3892/mco.2013.200
Pages: 59-64

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple myeloma is a primary malignancy of bone marrow characterized by the clonal proliferation of plasma cells and production of monoclonal immunoglobulin. The disease occurs more frequently in males, with the average age at diagnosis being ~60 years. The first manifestation of multiple myeloma is varied and depends on the sites and extent of involvement. The predominant clinical symptoms of multiple myeloma are associated with bone pain and renal dysfunction. Neoplastic cells usually produce large amounts of monoclonal immunoglobulin light or heavy chains that can be detected in serum or urine, while plasmacytoma may be identified on marrow biopsy. The present study reported on the case of a 69‑year‑old male patient presenting with a complaint of a painful lesion in the left maxilla. Physical examination, imaging, laboratory investigations and biopsy were conducted, confirming the diagnosis of multiple myeloma. The results obtained suggest that the dentist should address oral manifestations as first indications of multiple myeloma.

View Figures

View References

1.	Seoane J, Aguirre-Urizar JM, Esparza-Gomez G, Suarez-Cunqueiro M, Campos-Trapero J and Pomareda M: The spectrum of plasma cell neoplasia in oral pathology. Med Oral. 8:269–280. 2003.(In English).
2.	Dinter DJ, Neff WK, Klaus J, Bohm C, Hastka J, Weiss C, Schoenburg SO and Metzgeroth G: Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol. 88:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Mulligan ME and Badros AZ: PET/CT and MR imaging in myeloma. Skeletal Radiol. 36:5–16. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Beers MH, Porter RS, Jones TV, Kaplan JL and Berkwits M: The Merck Manual of Diagnosis and Therapy. 18th edition. Merck Research Laboratories; Whitehouse Station, NJ: pp. 1129–1131. 2006
5.	Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS and Devesa SS: Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004. Br J Hematol. 144:86–94. 2009.
6.	Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar V, Offord JR, Larson DR, et al: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 78:21–33. 2003. View Article : Google Scholar : PubMed/NCBI
7.	Mai Y, Qiu L and Li R: The clinical and laboratory features of 432 patients with multiple myeloma. J Leuk Lymphoma. 13:198–201. 2004.
8.	Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, et al: Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J. 4:379–398. 2003. View Article : Google Scholar : PubMed/NCBI
9.	Greipp PR, San Miguel J, Durie BG, et al: International staging system for multiple myeloma. J Clin Oncol. 23:3412–3420. 2005. View Article : Google Scholar : PubMed/NCBI
10.	International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 121:749–757. 2003. View Article : Google Scholar
11.	Bird JM, Owen RG, D’Sa S, Snowden JA, Pratt G, et al: Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol. 154:32–75. 2011. View Article : Google Scholar : PubMed/NCBI
12.	Nau KC and Lewis WD: Multiple myeloma: diagnosis and treatment. Am Fam Physician. 78:853–859. 2008.PubMed/NCBI
13.	Ashcroft AJ, Davies FE and Morgan GJ: Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. Lancet Oncol. 4:284–292. 2003. View Article : Google Scholar : PubMed/NCBI
14.	Epstein JB, Emerton S, Guglietta A and Le N: Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer. Oral Oncol. 33:359–363. 1997. View Article : Google Scholar : PubMed/NCBI
15.	Mozaffari E, Mupparapu M and Otis L: Undiagnosed multiple myeloma causing extensive dental bleeding: report of a case and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 94:448–453. 2002. View Article : Google Scholar : PubMed/NCBI
16.	Pinto LS, Campagnoli EB, Leon JE, et al: Maxillary lesion presenting as a first sign of multiple myeloma: case report. Med Oral Patol Oral Cir Bucal. 12:E344–E347. 2007.PubMed/NCBI
17.	Shah A, Ali A, Latoo S and Ahmad I: Multiple Myeloma presenting as Gingival mass. J Maxillofac Oral Surg. 9:209–212. 2010. View Article : Google Scholar
18.	Zachriades N, Papanicolaou S, Papavassiliou D, Vairaktaris E, Triantafyllou D and Mezitis M: Plasma cell myeloma of the jaws. Int J Oral Maxillofac Surg. 16:510–515. 1987. View Article : Google Scholar : PubMed/NCBI
19.	Pisano JJ, Coupland R, Chen SY and Miller AS: Plasmacytoma of the oral cavity and jaws: a clinicopathologic study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:265–271. 1997. View Article : Google Scholar : PubMed/NCBI
20.	Hsi ED and Yegappan S: Lymphoma immunophenotyping: a new era in paraffin-section immunohistochemistry. Adv Anat Pathol. 8:218–239. 2001. View Article : Google Scholar : PubMed/NCBI
21.	Bayer-Garner IB, Prieto VG and Smoller BR: Detection of clonality with κ and λ immunohistochemical analysis in cutaneous plasmacytomas. Arch Pathol Lab Med. 128:645–648. 2004.
22.	Durie BG and Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 36:842–854. 1975. View Article : Google Scholar : PubMed/NCBI